Other Species / Isoforms
  DAP (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MssPPEGkL
0 5
DAP (human) ______MssPPEGkL S2-p
DAP (mouse) ______MssPPEGKL S2-p
DAP (rat) ______MSSPPEGkL S2
S3-p
_____MssPPEGkLE
Upstream
Downstream
1 15
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • autophagy, altered
Treatment
  • amino_acid_starvation
  • EGF
  • rapamycin
  • refeeding
  • Torin1
view more >
DAP (human) _____MssPPEGkLE S3-p
DAP (mouse) _____MssPPEGKLE S3-p
DAP (rat) _____MSSPPEGkLE S3
K8
MssPPEGKLETkAGH
0 1
DAP (human) MssPPEGKLETkAGH K8
DAP (mouse) MssPPEGKLETKAGH K8
DAP (rat) MSSPPEGkLETKAGH K8-ac
K8-ub
MssPPEGkLETkAGH
0 1
DAP (human) MssPPEGkLETkAGH K8-ub
DAP (mouse) MssPPEGKLETKAGH K8
DAP (rat) MSSPPEGKLETKAGH K8
K12-ub
PEGkLETkAGHPPAV
0 1
DAP (human) PEGkLETkAGHPPAV K12-ub
DAP (mouse) PEGKLETKAGHPPAV K12
DAP (rat) PEGkLETKAGHPPAV K12
K20-ac
AGHPPAVkAGGMRIV
0 1
DAP (human) AGHPPAVkAGGMRIV K20-ac
DAP (mouse) AGHPPAVKAGGMRIV K20
DAP (rat) AGHPPAVKVAGIRIV K20
K29
GGMRIVQKHPHTGDT
0 1
DAP (human) GGMRIVQKHPHTGDT K29
DAP (mouse) GGMRIVQKHPHTGDG K29
DAP (rat) AGIRIVQkHPHTGDG K29-ac
K29-ub
GGMRIVQkHPHTGDT
0 1
DAP (human) GGMRIVQkHPHTGDT K29-ub
DAP (mouse) GGMRIVQKHPHTGDG K29
DAP (rat) AGIRIVQKHPHTGDG K29
K37
HPHTGDTKEEKDKDD
0 2
DAP (human) HPHTGDTKEEKDKDD K37
DAP (mouse) HPHTGDGkEERDKDD K37-ac
DAP (rat) HPHTGDGkEKKDKDD K37-ac
S49-p
KDDQEWEsPsPPkPt
Upstream
0 23
Treatment
  • nocodazole
DAP (human) KDDQEWEsPsPPkPt S49-p
DAP (mouse) KDDQEWEstsPPKPt S49-p
DAP (rat) KDDQEWEStsPPkPT S49
P50
DDQEWEsPsPPkPtV
0 9
DAP (human) DDQEWEsPsPPkPtV P50
DAP (mouse) DDQEWEstsPPKPtV T50-p
DAP (rat) DDQEWEStsPPkPTV T50-p
S51-p
DQEWEsPsPPkPtVF
Upstream
Downstream
1 54
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • autophagy, altered
Kinase, in vitro:
  • mTOR (human)
Treatment
  • amino_acid_starvation
  • BI_4834
  • LRRK2-IN-1
  • nocodazole
  • rapamycin
  • refeeding
  • Torin1
view more >
DAP (human) DQEWEsPsPPkPtVF S51-p
DAP (mouse) DQEWEstsPPKPtVF S51-p
DAP (rat) DQEWEStsPPkPTVY S51-p
K54
WEsPsPPKPtVFISG
0 1
DAP (human) WEsPsPPKPtVFISG K54
DAP (mouse) WEstsPPKPtVFISG K54
DAP (rat) WEStsPPkPTVYISG K54-ac
K54-ub
WEsPsPPkPtVFISG
0 1
DAP (human) WEsPsPPkPtVFISG K54-ub
DAP (mouse) WEstsPPKPtVFISG K54
DAP (rat) WEStsPPKPTVYISG K54
T56-p
sPsPPkPtVFISGVI
0 5
DAP (human) sPsPPkPtVFISGVI T56-p
DAP (mouse) stsPPKPtVFISGVI T56-p
DAP (rat) StsPPkPTVYISGVI T56
K68-ac
GVIARGDkDFPPAAA
0 2
DAP (human) GVIARGDkDFPPAAA K68-ac
DAP (mouse) GVIARGDKDFPPAAA K68
DAP (rat) GVIARGDkDFPPAAA K68-ac
K81-ac
AAQVAHQkPHAsMDK
0 2
DAP (human) AAQVAHQkPHAsMDK K81-ac
DAP (mouse) AAQVAHQKPHASMDK K81
DAP (rat) AAQVAHQkPHASMDK K81-ac
S85-p
AHQkPHAsMDKHPsP
0 2
DAP (human) AHQkPHAsMDKHPsP S85-p
DAP (mouse) AHQKPHASMDKHVsP S85
DAP (rat) AHQkPHASMDKHVSP S85
S91-p
AsMDKHPsPrTQHIQ
Upstream
0 8
Treatment
  • nocodazole
DAP (human) AsMDKHPsPrTQHIQ S91-p
DAP (mouse) ASMDKHVsPRTQHIQ S91-p
DAP (rat) ASMDKHVSPRTQHIQ S91
R93-m1
MDKHPsPrTQHIQQP
0 1
DAP (human) MDKHPsPrTQHIQQP R93-m1
DAP (mouse) MDKHVsPRTQHIQQP R93
DAP (rat) MDKHVSPRTQHIQQP R93